BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 10641440)

  • 1. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
    Sao H; Kitaori K; Kasai M; Shimokawa T; Kato C; Yamanishi H; Ueda R; Morishima Y
    Int J Hematol; 1999 Jan; 69(1):27-35. PubMed ID: 10641440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of graft-versus-host disease with T cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukemic marrow recipients.
    Ringdén O; Pihlstedt P; Markling L; Aschan J; Båryd I; Ljungman P; Lönnqvist B; Tollemar J; Janossy G; Sundberg B
    Bone Marrow Transplant; 1991 Mar; 7(3):221-6. PubMed ID: 2059758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory control in predicting clinical efficacy of T cell-depletion procedures used for prevention of graft-versus-host disease: importance of limiting dilution analysis.
    Marciniak E; Romond EH; Thompson JS; Henslee PJ
    Bone Marrow Transplant; 1988 Nov; 3(6):589-98. PubMed ID: 3063328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow.
    Soiffer RJ; Murray C; Mauch P; Anderson KC; Freedman AS; Rabinowe SN; Takvorian T; Robertson MJ; Spector N; Gonin R
    J Clin Oncol; 1992 Jul; 10(7):1191-200. PubMed ID: 1607923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic marrow transplantation using T cell depletion for patients with juvenile chronic myelogenous leukemia without HLA-identical siblings.
    Bunin NJ; Casper JT; Lawton C; Murray K; Camitta BM; Greenwood M; Geil J; Ash RC
    Bone Marrow Transplant; 1992 Feb; 9(2):119-22. PubMed ID: 1571710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of acute GVHD by in vivo use of anti-interleukin-2 receptor monoclonal antibody (33B3.1): a feasibility trial in 15 patients.
    Blaise D; Olive D; Hirn M; Viens P; Lafage M; Attal M; Stoppa AM; Gabert J; Gastaut JA; Camerlo J
    Bone Marrow Transplant; 1991 Aug; 8(2):105-11. PubMed ID: 1933050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft-versus-host disease prevention in allogeneic bone marrow transplantation from histocompatible siblings. A pilot study using immunotoxins for T cell depletion of donor bone marrow.
    Filipovich AH; Vallera DA; Youle RJ; Haake R; Blazar BR; Arthur D; Neville DM; Ramsay NK; McGlave P; Kersey JH
    Transplantation; 1987 Jul; 44(1):62-9. PubMed ID: 3299923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti LFA1 monoclonal antibody for the prevention of graft rejection after T cell-depleted HLA-matched bone marrow transplantation for leukemia in adults.
    Maraninchi D; Mawas C; Stoppa AM; Gaspard MH; Marit G; Van Ekthoven A; Reiffers J; Olive D; Hirn M; Delaage M
    Bone Marrow Transplant; 1989 Mar; 4(2):147-50. PubMed ID: 2650783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell depletion in bone marrow transplantation for leukemia: current results and future directions.
    Butturini A; Gale RP
    Bone Marrow Transplant; 1988 May; 3(3):185-92. PubMed ID: 3048485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplantation in miniature swine. III. Graft-versus-host disease and the effect of T cell depletion of marrow.
    Sakamoto K; Sachs DH; Shimada S; Popitz-Bergez FA; Pennington LR; Pescovitz MD; McDonough MA; MacVittie TJ; Katz SI; Gress RE
    Transplantation; 1988 May; 45(5):869-75. PubMed ID: 3285532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cyclosporine as prophylaxis for graft versus host disease in adults undergoing allogeneic bone marrow transplantation].
    Matsushita T; Akatsuka Y; Towatari M; Takeyama K; Miyamura K; Sugihara T; Minami S; Kodera Y
    Rinsho Ketsueki; 1989 Apr; 30(4):429-36. PubMed ID: 2671437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cellular sorting methods in autologous (elimination of residual malignant cells) or allogeneic (T lymphocyte elimination) bone marrow grafts. Clinical pilot studies].
    Hervé P; Flesch M
    Nouv Rev Fr Hematol (1978); 1986; 28(2):97-105. PubMed ID: 2942838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Result of allogeneic bone marrow transplantation from unrelated donor].
    Yabe H; Kato S
    Rinsho Ketsueki; 1990 May; 31(5):614-9. PubMed ID: 2395212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of graft-versus-host disease by lymphocyte depletion of the bone marrow graft with use of counterflow centrifugation.
    Haanen C; De Witte T; Plas A; Schattemberg T
    Haematologica; 1991 Mar; 76 Suppl 1():22-8. PubMed ID: 1864551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings.
    Theobald M; Nierle T; Bunjes D; Arnold R; Heimpel H
    N Engl J Med; 1992 Dec; 327(23):1613-7. PubMed ID: 1435898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific ex-vivo depletion of human bone marrow T lymphocytes by an anti-pan-T cell (CD5) ricin A-chain immunotoxin.
    Siena S; Villa S; Bonadonna G; Bregni M; Gianni AM
    Transplantation; 1987 Mar; 43(3):421-6. PubMed ID: 3103275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of acute graft versus host disease using 3 prophylactic schemes].
    Conde E; Iriondo A; Richard C; Garijo J; Hermosa V; Pastor JM; Cuadrado MA; Recio M; Bureo E; Bello C
    Med Clin (Barc); 1989 Jun; 93(1):5-9. PubMed ID: 2671531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Allogeneic bone marrow transplantation].
    Shibata H
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3044-52. PubMed ID: 3056276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Problems and strategies for bone marrow transplantation in acute leukemia and chronic myelogenous leukemia.
    Santos GW
    Cancer Detect Prev; 1988; 12(1-6):589-96. PubMed ID: 3052840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of immunosuppressive drugs for prevention of graft-v-host disease after bone marrow transplantation.
    Devergie A; Esperou H; Traineau R; Varrin F; Lehn P; Gluckman E
    Nouv Rev Fr Hematol (1978); 1989; 31(2):73-5. PubMed ID: 2671932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.